Biotech by P/B ratio

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Biogen has the lowest figure of the 18 biotech ranked by P/B ratio, at 2.0, followed by Vaxcyte (3.5) and Neurocrine Biosciences (4.3). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
18
Lowest
Biogen2.0
Median
8.9
Combined market value
CHF 709.2B
Countries
5
Not ranked
6no P/B ratio on file

Market values as of .

Biotech by P/B ratio
#CompanyP/B ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care2.0CHF 31.2BCHF 211.08 0.10% down 49% up United States
2VaxcytePCVX · Health Care3.5CHF 7.8BCHF 49.50 1.09% down 22% up United States
3Neurocrine BiosciencesNBIX · Health Care4.3CHF 14BCHF 138.77 0.72% down 20% up United States
4RepligenRGEN · Health Care4.6CHF 9.2BCHF 143.46 5.00% up 5% up United States
5Bio-TechneTECH · Health Care5.3CHF 9.6BCHF 61.27 0.14% up 26% up United States
6Krystal BiotechKRYS · Health Care6.3CHF 7.6BCHF 255.34 1.52% up 46% up United States
7Kymera TherapeuticsKYMR · Health Care6.4CHF 8.8BCHF 102.63 0.25% up 87% up United States
8CG OncologyCGON · Health Care7.0CHF 5.9BCHF 65.76 1.12% down 85% up United States
9Twist BioscienceTWST · Health Care8.7CHF 6.5BCHF 95.49 1.20% up 340% up United States
10ExelixisEXEL · Health Care9.1CHF 14.1BCHF 57.76 0.09% up 63% up United States
11ImmunovantIMVT · Health Care10.5CHF 5.8BCHF 28.08 0.38% up 43% up United States
12ModernaMRNA · Health Care12.0CHF 69BCHF 170.61 2.08% down 755% up United States
13Revolution MedicinesRVMD · Health Care14.3CHF 28.9BCHF 133.61 2.52% down 131% up United States
14Gilead SciencesGILD · Health Care16.1CHF 176.7BCHF 142.47 0.68% down 33% up United States
15AmgenAMGN · Health Care16.9CHF 204.8BCHF 378.68 1.85% down 34% up United States
16Adaptive BiotechnologiesADPT · Health Care26.0CHF 3.9BCHF 23.92 0.35% down 88% up United States
17Scholar Rock HoldingSRRK · Health Care34.0CHF 4.8BCHF 39.66 4.43% up 14% up United States
18Kodiak SciencesKOD · Health Care492CHF 5.3BCHF 81.22 0.41% down 396% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8425 CHF). 6 companies have no P/B ratio on file and are not ranked here.

Questions and answers

Which biotech have the lowest P/B ratio?

Biogen (2.0), Vaxcyte (3.5) and Neurocrine Biosciences (4.3) have the lowest P/B ratio of the 18 biotech ranked here as of 18 Nov 2026, 14:51 UTC.

How many biotech are in this ranking?

18 are ranked by P/B ratio. 6 more have no P/B ratio on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 18 biotech ranked by P/B ratio have a combined market value of CHF 709.2B as of 18 Nov 2026, 14:51 UTC.

What does ranking by P/B ratio measure?

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Cite this page

Funkfolio, “Biotech by P/B ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=pb-ratio

Underlying data: Yahoo Finance; SEC EDGAR.